2 Pediatric Indications Sought for Golimumab
Baricitinib Studied as Possible COVID-19 Treatment; Plus Ranitidine Removed from U.S. Market
U.S. FDA Warns Against Using Hydroxychloroquine for COVID-19
FDA Cautions Slower Drug Review Activity Due to Staff Reallocation for COVID-19
FDA Considers Tanezumab Application for Chronic OA Pain
Yes, the FDA Employs Rheumatologists. Here’s Their Role.
FDA Approves Meloxicam Injection & OTC Diclofenac Sodium Topical Gel for Pain Management
FDA Accelerates Approvals of Generic Versions of HCQ
Tocilizumab Begins Clinical Trial for COVID-19
- 1
- 2
- 3
- …
- 8
- Next Page »